- Editorial: screening for oesophageal varices after directly acting anti‐viral therapy—do not let your guard down
Sahaj Rathi et al, 2019, Alimentary Pharmacology & Therapeutics CrossRef - Consensus Guidelines: Best Practices for Detection, Assessment and Management of Suspected Acute Drug-Induced Liver Injury During Clinical Trials in Adults with Chronic Viral Hepatitis and Adults with Cirrhosis Secondary to Hepatitis B, C and Nonalcoholic Steatohepatitis
William R. Treem et al, 2021, Drug Safety CrossRef - Suppression of complement component 2 expression by hepatitis B virus contributes to the viral persistence in chronic hepatitis B patients
Gang Ning et al, 2020, Journal of Viral Hepatitis CrossRef - Nucleos(t)ide analogues and Hepatitis B virus-related hepatocellular carcinoma: A literature review
Mohamed A Abd El Aziz et al, 2020, Antiviral Chemistry and Chemotherapy CrossRef - Mortality trends in chronic liver disease and cirrhosis from 1981 to 2015 in Taiwan
Shih-Yung Su et al, 2021, Population Health Metrics CrossRef - Population-based study of Entecavir and long-term mortality in chronic hepatitis B–related decompensated liver cirrhosis
Tsung-Hsing Hung et al, 2019, Clinics and Research in Hepatology and Gastroenterology CrossRef - The clinical efficacy and adverse effects of Entecavir plus Thymosin alpha-1 combination therapy versus Entecavir Monotherapy in HBV-related cirrhosis: a systematic review and meta-analysis
Dan Peng et al, 2020, BMC Gastroenterology CrossRef - Current Management of Chronic HBV Infection
Nese Inan et al, 2018, Viral Hepatitis: Chronic Hepatitis B CrossRef